Preservation

Part of Vaccines

Methods for maintaining vaccine potency and preventing contamination during storage and transport.

Why This Matters

The time between vaccine preparation and administration is a period of continuous degradation. Biological molecules unfold. Living organisms die. Contaminating bacteria grow. Physical separation of components occurs. Without active preservation, a vaccine that was potent on the day of production may be worthless — or dangerous — a week later.

Preservation extends the useful life of vaccine materials, enables stockpiling, and makes distribution over distances possible. The first vaccines — cowpox lymph transported from England to the Americas in the early 19th century — were preserved in glycerol sealed in glass capillary tubes. This low-technology approach kept viable material alive for months of ocean voyage.

Understanding preservation methods allows a rebuilding society to extend the reach of vaccination programs beyond immediate production sites, to stockpile materials before campaigns, and to maintain working reference stocks of vaccine organisms for future production.

Physical Preservation: Cold Storage

Cold temperature is the most broadly effective and easily understood preservation method. Low temperature:

• Reduces enzymatic activity (proteins denature more slowly)
• Reduces bacterial and fungal growth rates
• Reduces chemical reaction rates (oxidation, hydrolysis)
• Slows loss of biological activity

Temperature guidelines:

Storage Temperature	Method	Duration Extension
+4°C (ice)	Ice chest, icehouse	Days to weeks (depending on organism)
0°C (melting ice)	Continuous ice, ice water bath	Better than +4°C for most
−20°C (deep freeze)	Not available in most rebuilding contexts	Months to years
−70°C (ultra-cold)	Not practical without electricity	Very long-term

Achieving ice temperatures without electricity:

• Harvest and store natural ice (see Cold Chain)
• Underground spring water maintains near 4-8°C year-round
• Evaporative coolers reduce temperature by 10-15°C below ambient in dry climates
• Night cooling: temperatures drop significantly after dark; use this window for restocking ice chests

Important: Cold storage slows degradation; it does not stop it entirely. Every vaccine has a defined shelf life even under ideal cold storage. Document production date and discard when that period expires.

Glycerol Preservation

Glycerol (glycerin) at 50% v/v in water has been the standard preservation medium for live viral vaccines, particularly vaccinia (smallpox), for over a century.

Mechanism:

• Glycerol is a humectant — it retains moisture, preventing desiccation
• It has mild antimicrobial properties, inhibiting bacterial contamination
• At 50% concentration, it reduces enzymatic activity that would degrade vaccine material
• It does not freeze at temperatures above −13°C, preventing ice crystal damage

Preparation:

1. Obtain pharmaceutical-grade glycerol (or pure glycerol from soap-making process — byproduct of saponification).
2. Mix equal volumes of glycerol and sterile water (50:50 by volume).
3. Autoclave or boil to sterilize.
4. After cooling, mix with equal volume of vaccine material (resulting in 25% glycerol in final product — adjust based on historical protocol for specific vaccine).
5. Seal in glass tubes or vials; label.

For vaccinia/cowpox lymph: The traditional preparation was glycerol-lymph: 50-75% glycerol with vaccine lymph. At 4°C, this preparation maintained viability for months. At room temperature (temperate climates, 15-20°C), it remained viable for 1-2 weeks — enough for extensive distribution.

Glycerol from soap production: Saponification of animal fats or plant oils produces glycerol as a byproduct. The crude glycerol layer in soap production can be separated, purified by filtration and distillation, and used for biological preservation purposes. See Vaccine Preparation for purification steps.

Chemical Preservatives

Chemical preservatives prevent bacterial contamination of multi-dose vials during repeated use.

Phenol: 0.25-0.5% phenol added to bacterial vaccines provides antimicrobial preservation. It was the standard preservative for typhoid vaccine, cholera vaccine, and others throughout the 20th century.

Sources: coal tar distillation, creosote from wood tar. Phenol is toxic at higher concentrations; ensure no more than 0.5% in final product.

Thimerosal: An organic mercury compound. Highly effective antimicrobial preservative at very low concentrations (0.01%). Used widely in multi-dose vials. No longer used in single-dose vaccines in most regions due to mercury concerns, though evidence of harm at used concentrations is limited.

Thimerosal is not practically synthesizable in a rebuilding context without chemical industry. Useful only from existing medical stockpiles.

Merthiolate (same as thimerosal): If present in any existing antiseptic preparations, can be extracted as a vaccine preservative. The antimicrobial concentration for preservation (0.01%) is far below the antiseptic concentration — a little goes a very long way.

Benzalkonium chloride: A quaternary ammonium compound used as antiseptic. Can serve as preservative in some vaccine preparations. Not compatible with all vaccine types — may inactivate some live organisms.

Lyophilization (Freeze-Drying)

Freeze-drying is the gold standard for long-term vaccine preservation: vaccines are frozen and then dried under vacuum, removing water while maintaining antigen structure. The resulting powder is stable at room temperature for years.

Why it works: Biological degradation requires water as a medium. Remove water, and most degradation reactions essentially stop. Freeze-drying preserves structure while removing water by sublimation (ice directly converting to vapor) — gentler than heat-drying which destroys biological molecules.

Practical feasibility: Freeze-drying requires:

• Capability to freeze material (below −20°C)
• Vacuum system to reduce pressure
• Cold condenser to trap water vapor
• Controlled temperature cycling

This is achievable in a developing laboratory setting with compressed gas technology or mechanical pumps. It does not require advanced electricity — some historical lyophilization systems used mechanical hand pumps and natural ice.

Improvised freeze-drying approach: In cold climates during winter, outdoor temperatures below −20°C may allow natural freezing. Coupled with a simple mechanical vacuum pump over the frozen material, basic freeze-drying is theoretically achievable. The resulting product would be cruder than commercial lyophilized vaccines but more stable than liquid preparations.

Stabilizers for lyophilization: Before freeze-drying, add stabilizers to protect biological activity during the process:

• Sugars: sucrose, trehalose, lactose — replace water in hydrogen bonding with proteins during drying
• Proteins: human serum albumin, gelatin — stabilize virus particles
• Buffers: maintain pH during process

A simple stabilizer formulation: 5% sucrose + 0.5% gelatin in phosphate-buffered saline.

Sealing and Container Selection

Glass: Glass is the ideal container for vaccine storage. It is impermeable, can be sterilized by heat, is compatible with essentially all biological materials, and can be sealed hermetically (completely airtight). Glass capillary tubes sealed with flame were used for smallpox vaccine distribution for over a century.

Preparation of glass vials:

1. Clean with water and detergent; rinse thoroughly.
2. Sterilize by baking at 180°C for 2 hours (also removes endotoxins).
3. Fill with vaccine material under sterile conditions.
4. Seal: rubber stoppers (boil 30 minutes before use), wax seal over cork, or flame-seal for capillary tubes.

Desiccants: For lyophilized vaccines, include a desiccant (silica gel, or burned clay) in the sealed container to absorb any residual water. This extends stability significantly.

Aluminum foil wrapping: If available, wrapping glass vials in aluminum foil protects from light exposure (ultraviolet light degrades many biological preparations rapidly).

Clay or ceramic containers: As a last resort, ceramic containers with tight-fitting baked clay stoppers can store vaccines. They are less impermeable than glass but better than organic materials (wood, leather) which leach compounds into preparations.

Monitoring and Expiry Management

Labeling requirements for every batch:

• Production date
• Expiry date (based on preservation method and organism)
• Storage conditions required
• Lot number
• Contents

Shelf life guidelines by preservation method (general):

Method	Temperature	Approximate Shelf Life
Liquid, no preservative	4°C	Days to 1-2 weeks
Glycerol-preserved	4°C	Weeks to months
Phenol-preserved	4°C	Months
Lyophilized	Room temperature	1-5 years
Lyophilized	4°C	5-10 years

These are general guidelines; specific organisms vary considerably. Validate shelf life by potency testing (animal protection test) if storage is longer than expected.

First-in, first-out: Older material is always used before newer material. Label and rotate stock systematically. Discard expired material — do not use materials past stated shelf life without fresh potency verification.

Using expired vaccine that has lost potency provides no protection while appearing to. This is worse than no vaccination — it creates false confidence and may delay recognition of an outbreak.